Authors: Martha Powell, Future Science Group
With World Tuberculosis Day on March 24th, we at Infectious Diseases Hub took this opportunity to speak to Timothy Rodwell, acting head of the TB Program at FIND (Geneva, Switzerland) and an Associate Professor in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of California San Diego (CA, USA).
In this interview, Rodwell shares his thoughts on the challenges currently facing diagnostics in TB, both in implementing current diagnostics and in developing new tools. In addition, he discusses the FIND strain and sample bank, a unique and in-demand resource that aims to facilitate research and development in the fight against TB.
Rodwell’s research is primarily focused TB on with an emphasis on the molecular epidemiology of drug resistance, and the development and implementation of rapid molecular diagnostics. He is currently overseeing several large multinational studies to develop, test and implement novel instruments for rapid clinical diagnosis of drug-resistant TB and leading an effort to implement an end-to-end next-generation sequencing solution for culture-free diagnosis and surveillance of drug-resistant TB in low- and middle-income countries. Find out more below.
You can learn more about FIND’s work in TB diagnostics at www.finddx.org.
A good review of TB: http://www.nature.com/articles/nrdp201676
The most recent WHO TB report: http://www.who.int/tb/publications/global_report/en/